BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7681318)

  • 1. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia.
    Nissen C; Gratwohl A; Tichelli A; Stebler C; Würsch A; Moser Y; Dalle Carbonare V; Signer E; Buser M; Ritz R
    Br J Haematol; 1993 Feb; 83(2):319-25. PubMed ID: 7681318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls.
    Tong J; Bacigalupo A; Piaggio G; Figari O; Marmont A
    Br J Haematol; 1989 Dec; 73(4):546-50. PubMed ID: 2692693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
    Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
    Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained trilineage response in a patient with ALG-resistant severe aplastic anaemia after treatment with G-CSF, erythropoietin and cyclosporin A: association of recovery with marked elevation of serum alkaline phosphatase.
    Weide R; Lyttelton M; Samson D; Görg C; Köppler H; Pflüger KH; Havemann K
    Br J Haematol; 1993 Nov; 85(3):608-10. PubMed ID: 7510993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete recovery of marrow function after treatment with anti-lymphocyte globulin is associated with high, whereas early failure and development of paroxysmal nocturnal haemoglobinuria are associated with low endogenous G-CSA-release.
    Nissen C; Moser Y; dalle Carbonare V; Gratwohl A; Speck B
    Br J Haematol; 1989 Aug; 72(4):573-7. PubMed ID: 2789075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of aplastic anaemia with antilymphocyte globulin (ALG).
    Fairhead SM; Chipping PM; Gordon-Smith EC
    Br J Haematol; 1983 Sep; 55(1):7-16. PubMed ID: 6882689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
    Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
    Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of immunosuppressive therapy for aplastic anemia].
    Teramura M; Saito H; Kobayashi S; Hoshino S; Oshimi K; Mizoguchi H
    Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe aplastic anemia].
    Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Leibundgut U; Ruggero D; Osterwalder B; Burri HP; Cornu P; Jeannet M
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):860-3. PubMed ID: 6783204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antilymphocyte globulin in the treatment of chronic acquired bone marrow failure.
    Marsh JC; Gordon-Smith EC
    Blood Rev; 1988 Sep; 2(3):141-8. PubMed ID: 3052659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).
    de Planque MM; Bacigalupo A; Würsch A; Hows JM; Devergie A; Frickhofen N; Brand A; Nissen C
    Br J Haematol; 1989 Sep; 73(1):121-6. PubMed ID: 2803967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow graft versus ALG in patients with aplastic anaemia.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Biomed Pharmacother; 1983; 37(3):139-43. PubMed ID: 6357304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.